コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ere infected with HCV and 4,728 (81.8%) were viremic.
2 subsequent RNA testing revealed that 3 were viremic.
3 en aged <10 years hospitalized with CAP were viremic.
4 oculated orally-nasally, became persistently viremic.
5 llected at enrollment and were classified as viremic.
6 s in feces; two seroconverted and one became viremic.
7 nd in horses worldwide with approximately 3% viremic.
8 eir HIV infection and 2,816 (69.5%) were HIV viremic.
9 imal by 20 weeks, the second animal remained viremic (103 to 107 genome equivalents per ml) for >2 ye
11 oscleral rims from 4 patients: 1 patient was viremic, 2 were viremic and IgM positive, and 1 was IgM
12 all anti-HCV-positive cases), 175 (61%) were viremic (3.8% overall prevalence in cohort), which was 5
13 re unaware of their status and those who are viremic across 26 Indian cities at various epidemic stag
15 The main group of 346 lead-in nonresponders (viremic after 24 weeks of peginterferon-ribavirin therap
16 9 on ADV-TDF), and for patients who remained viremic after the addition of FTC (7/20 on TDF and 5/14
17 dy, we dissected the function of NK cells in viremic and aviremic HIV-1-infected subjects, as well as
19 was evaluated in B cells from HIV-1-infected viremic and aviremic subjects and healthy subjects, in c
21 e I interferon (IFN) receptor (IFNAR) became viremic and died of infection after a high-dose vaginal
22 subjects who were HCV seronegative, both HCV viremic and HCV aviremic individuals were at increased r
25 .9%) had anti-HCV antibodies, 54 (2.1%) were viremic and of those, 52 (2.1%) agreed to IL28B testing.
30 pecimens from 12 donors who were or were not viremic and were or were not seropositive were investiga
31 Twelve apparently uninfected donors were viremic and/or positive for immunoglobulin M (IgM) and/o
32 h chronic HBV infection (118 aviremic and 67 viremic) and compared them with pDCs from uninfected ind
33 A total of 52 602 HCV seronegative, 9508 HCV viremic, and 913 HCV aviremic subjects were included.
34 l, 57 of 570 (10%) RV-positive patients were viremic, and all were children aged <10 years (n = 57/37
35 ipients of donor tissue from seropositive or viremic animals, five became viremic and three died with
37 udies--Maraviroc versus Optimized Therapy in Viremic Antiretroviral Treatment-Experienced Patients (M
39 nt proportion (22%) of patients who were HIV viremic at baseline had undetectable HIV RNA at week 12.
40 of HCV infection from cardiac donors who are viremic at the time of organ donation occurs with high f
41 virus (HCV) recurrence in recipients who are viremic at time of liver transplantation (LT) is univers
46 , mosquitoes become infected when feeding on viremic birds and subsequently transmit the virus to sus
49 ing West Nile virus (WNV) infection, acutely viremic blood donors, identified by nucleic acid amplifi
53 Nine patients and 1 healthy volunteer were viremic but had seronegative test results for JCV antibo
54 us dendritic cells (DCs) from HIV-1-infected viremic but not aviremic individuals are markedly impair
56 es were detected in 13 (92.86%) of 14 HPgV-2-viremic cases, and NS4AB antibodies were detected in 8 (
58 ion index, 20), in contrast with only 1 of 9 viremic children (median p24 stimulation index, 2.0; p =
61 mature NK cells were significantly lower in viremic children with a history of decreasing CD4+ cell
64 4 expression was increased on B cells of HIV-viremic compared with HIV-aviremic and HIV-negative indi
65 iring various aspects of NK cell function in viremic condition, and several viral factors contribute
67 inued emphasis by HIV care providers on both viremic control and preventive measures including smokin
68 y potent bNAbs not only resulted in complete viremic control but also led to a reduction in cell-asso
69 n of ART and immunotherapy enabled prolonged viremic control by a single bNAb after ART was withdrawn
70 s in HIV-1YU-2-infected humanized mice, with viremic control exhibited when a third antibody, 10-1074
73 viduals with protective HLA class I alleles, viremic control was associated with broad CD8(+) T cells
77 95% confidence interval {CI}, 0.35%-0.80%]), viremic controllers (ie, subjects with plasma HIV RNA le
78 rs (n = 16; viral load [VL], <75 copies/ml), viremic controllers (n = 14; VL, 75 to 2,000 copies/ml),
82 HLA-B*57 compared to twenty-three percent of viremic controllers and nine percent of noncontrollers (
85 we show that CD8(+) T cells from 2 out of 4 viremic controllers were capable of effectively eliminat
87 ontrollers" (viral load < 75 copies/mL), 11 "viremic controllers" (75-2000 copies/mL), 14 noncontroll
88 64), those with levels of 50-2000 copies/mL (viremic controllers, n = 60); we also examined HIV-speci
92 elite controllers (HIV-RNA < 75 copies/ml), "viremic" controllers (low-level viremia without therapy)
93 background), when directly blood-fed on 141 viremic dengue patients, have lower dengue virus (DENV)
94 cted subjects who were HCV seronegative, HCV viremic (detectable HCV RNA), or HCV aviremic (HCV serop
95 by minipool testing, yielding 183 confirmed viremic donations (0.027 percent, or 1 in 3703 donations
96 yield data and vice versa, and suggest that viremic donations will be rare relative to clinical dise
98 nly observed in recipients of blood from the viremic donor; transfer of SRV provirus and unintegrated
99 total of 84% of the specimens obtained from viremic donors before IgM/IgG seroconversion demonstrate
103 ially so in memory B cells from HIV-positive viremic donors, suggesting a possible underlying mechani
105 -positive IDUs (16 [94%] of 17 IDUs) than in viremic EIA-positive IDUs (9 [45%] of 20 IDUs) (P= .003)
108 000 copies/mL) and minor (50-1000 copies/mL) viremic episodes (VEs) and factors associated with major
109 lly distinct viral variants during recurrent viremic episodes is thought to be due to adaptive immune
111 by 6 replicate TMA tests; samples that were viremic for >40 days were tested for WNV-neutralizing ac
112 Non-pregnant and pregnant animals remain viremic for 21 days and for up to at least 57 days, resp
114 ts at baseline, and any patient who remained viremic (HBV DNA 400 copies/mL [69 IU/mL]) at week 288 o
116 ith a cohort of post-OLT and nontransplanted viremic HCV patients, the index patient with HCV clearan
119 irect IFN-alpha stimulation was defective in viremic HIV infection, and this defect was not attributa
123 ion with IL-7, however, was diminished among viremic HIV(+) donors and occurred independent of antige
124 ) expression was seen in CD4(+) T cells from viremic HIV(+) subjects compared to controls or followin
125 ood ILCs were severely depleted during acute viremic HIV-1 infection and that ILC numbers did not rec
126 Taken together, these data demonstrate that viremic HIV-1 infection is associated with a reduction i
127 g mechanisms leading to immune activation in viremic HIV-1 infection, however, are not fully understo
132 ed gene expression in low- versus high-level viremic HIV-1 patients, suggesting a shift in apoptosis
133 on was highly increased in DCs isolated from viremic HIV-1 patients, suggesting that CD8(+) T cells a
134 nal cost a substantial number of unaware and viremic HIV-infected and HCV-infected individuals who we
135 l CD56(dim) NK cells increased in cART-naive viremic HIV-infected individuals (median [interquartile
136 cts in signaling were observed in cells from viremic HIV-infected persons and were especially pronoun
137 e populations are significantly increased in viremic HIV-infected subjects as compared with healthy s
140 cell inhibitory and activating receptors in viremic human immunodeficiency virus (HIV)-infected pati
143 ss, but found a substantial population to be viremic, in need of ART, and at risk for transmission.
145 ntibodies to E2 were detected in most HPgV-2-viremic individuals (92.86%), as is observed among indiv
146 an immunodeficiency virus (HIV)-infected and viremic individuals exhibit elevated levels of plasma cy
149 dysfunctional CD56(-) NK cell subset in HIV-viremic individuals largely accounts for the impaired fu
151 ion in the absence of HCV viremia, while HCV-viremic individuals who previously were PWID continue to
152 a of HIV-infected individuals, especially in viremic individuals, and correlated with serum immunoglo
153 in levels were also elevated in HIV-infected viremic individuals, especially IgG, and correlated with
154 mber in the peripheral blood of HIV-infected viremic individuals, in whom they are associated with B-
155 lute CD4(+) T cell loss is more common among viremic individuals, suggesting that even very low-level
165 tory syndrome virus (PRRSV) causes an acute, viremic infection of 4 to 6 weeks, followed by a persist
168 mononuclear cells from healthy controls and viremic KTR were stimulated using BK virus peptide libra
173 nfected humans, we examined the plasma of 13 viremic macaques infected with SHIVSF162P3Nand 85 HIV-1-
179 LdT and LAM use in late pregnancy for highly viremic mothers was equally effective in reducing MTCT.
185 ducted a cross-sectional study of cART-naive viremic patients (ART(-)), virologically suppressed pati
187 C samples showed little variation for either viremic patients (median fold differences of 0.80 and 0.
188 heral blood mononuclear cells (PBMCs) from 5 viremic patients and 20 patients receiving effective ART
189 n by first analyzing monocytes isolated from viremic patients and patients undergoing antiretroviral
190 s, we cloned full-length Envs from plasma of viremic patients and tested their apoptosis-inducing pot
191 tible as or more susceptible than cells from viremic patients and uninfected donors to HIV-1 entry an
192 state of resting CD4(+) T cells in infected viremic patients and, in turn, allows release of HIV-1 w
193 resting CD4(+) T cells from the majority of viremic patients are capable of producing cell-free HIV-
194 formed at the baseline for all patients, for viremic patients at week 144 or at the last time when th
195 IFN-alpha in response to HIV than pDCs from viremic patients but similar levels to pDCs from healthy
196 6(+) intermediate monocytes were elevated in viremic patients compared to those in uninfected control
197 tly upregulated in resting CD4(+) T cells of viremic patients compared to those of aviremic patients.
198 T cells was clearly observed in HIV-infected viremic patients compared with aviremic patients with co
204 were observed in the B cells of HIV-infected viremic patients in the context of B cell receptor stimu
205 d terminal differentiation in B cells of HIV-viremic patients lead to an increased propensity to cell
206 ivation, the low CD4 expression by pDCs from viremic patients may explain the weak IFN-alpha response
207 The ability to analyze archival species in viremic patients may have clinical utility in detecting
209 Characteristics of Vgamma2Vdelta2 T cells in viremic patients reflect both active responses (increasi
210 ly after transplantation, the liver graft of viremic patients universally becomes infected by circula
211 fective B cell costimulatory function in HIV-viremic patients was associated with low induction of CD
212 l sequences from the resting CD4+ T cells of viremic patients were found to be genetically distinct f
213 42 genes were up-regulated in B cells of HIV-viremic patients when compared with HIV-aviremic and HIV
217 f hepatitis B virus (HBV) e antigen-positive viremic patients with normal liver function and the inco
219 infection: primary HIV infection, long-term viremic patients, aviremic patients treated with highly
220 amma2Vdelta2 T cells were more pronounced in viremic patients, compared with antiretroviral therapy r
221 We also demonstrate that in HIV-infected viremic patients, expression of iNKRs was well conserved
223 ated that CD21(low) B cells, enhanced in HIV-viremic patients, were largely responsible for the chang
224 response of CD4(+) T cells to B cells of HIV-viremic patients, while the addition of exogenous CD28 l
238 emiology include viremia titer, variation in viremic period, enhanced viremias, and threshold viremia
239 IV-1 latency, reservoir stability, low-level viremic persistence, and emergence of intermittent viral
240 The CVD mortality rate was highest among viremic persons (adjusted rate ratio [RR], 3.53 [95% con
242 V) genotype C is associated with a prolonged viremic phase, delayed hepatitis B e antigen (HBeAg) ser
243 severe disease progression during the acute viremic phase, they cleared the virus faster and did not
247 bility of success if administered before the viremic phase; however, because vascular leakage is asso
248 egulation or hypoferremia during the primary viremic phases of HCV or HBV infection; serum iron margi
249 tion of individual library HCVpp by the last viremic plasma sample obtained before clearance was comp
250 lemented, there is a need to identify acute (viremic preseroconversion) infections and to discriminat
252 studied the integration profile of HIV-1 in viremic progressors, individuals receiving antiretrovira
255 (Eomes) differentiated LTR controllers from viremic relapsers and reciprocally correlated with granz
256 on differentiated LTR controllers from early viremic relapsers, correlating with granzyme B loading a
262 ol of central memory CD4(+) T lymphocytes in viremic SIV-infected sooty mangabeys and protect against
265 is activity, HBeAg seroconversion, and a low viremic state earlier than those carrying wild-type HBV.
266 re compared between controllers (n = 33) and viremic subjects (n = 27) using overlapping peptides, ma
268 , and decreased levels of BTLA expression in viremic subjects compared to aviremic subjects and healt
269 gous plasma viral sequences from both EC and viremic subjects frequently harbored the typical cytotox
272 Compared with HCV seronegative subjects, HCV viremic subjects were at increased risk for stage 3 CKD
277 eceptor+ NK cells were stable or elevated in viremic subjects, while the numbers of CD3-/CD56+/CD94+
278 uses and clinical confirmation of a critical viremic threshold for vascular delivery and intratumoral
279 (-/-) mice infected with LCMV Cl 13 remained viremic throughout life from defects in the adaptive ant
280 ce as well as the relationship of disease to viremic titer remain unclear due to wide variation in st
282 h a low level of viremia, with 14 additional viremic units detected by prospective testing of individ
286 ruses a concern exists, that spillovers from viremic vaccinees could result in introduction of geneti
287 y with serum or intestinal contents from the viremic virulent HRV-inoculated pigs developed diarrhea,
289 .1) million noninstitutionalized people were viremic, which dropped to 1.9 (95% CI, 1.4-2.6) million
290 ble PVLs (<150 copies/mL), and 77 (72%) were viremic with a median PVL of 5450 copies/mL (interquarti
292 th HCV-seronegative participants and (2) HCV-viremic with successfully treated nonviremic patients.
296 The AIDS risk was greater among HCV-positive viremic women in the highest tertile compared with the l
297 ned for anti-HCV antibodies and HCV RNA, and viremic women were tested for quantitative HCV RNA at 3,
298 n with HIV coinfection, and 407 HCV-positive viremic women with HIV coinfection (median follow-up tim
300 r children born to HCV antibody-positive and viremic women, aged >/=18 months, separately by maternal
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。